Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy
1 other identifier
observational
400
1 country
1
Brief Summary
This is an observational study in which data on consecutive patients who undergo ureterorenoscopy with the use of a flexible ureterorenoscope are collected. In total 20 new ureteroscopes are usedfrom Olympus andfrom Storz) to study the durability of the ureteroscopes and the possible microbiological load.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2015
CompletedStudy Start
First participant enrolled
December 1, 2015
CompletedFirst Posted
Study publicly available on registry
March 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedApril 10, 2018
April 1, 2018
2 years
November 19, 2015
April 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Microbiological load
To evaluate the pre-operative microbiological load of the tip and the working channel of the most common used flexible ureteroscopes, after high level disinfection
2 years
Secondary Outcomes (2)
Durability
2 years
Factors affecting durability
2 years
Eligibility Criteria
The study population compromises those patients of over eighteen years old diagnosed to undergo a ureterorenoscopy (diagnostic or therapeutic) with a flexible ureterorenoscope.
You may qualify if:
- Patient presented with a diagnosis to undergo a ureterorenoscopy using a flexible ureterorenoscope
- over 18 years
- has signed informed consent
- the patient is being treated with the designated flexible ureterorenoscope
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AMC University Hospital
Amsterdam, 1105AZ, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jean de la Rosette, MD, PhD
Clinical Research Office of the Endourological Society
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2015
First Posted
March 23, 2017
Study Start
December 1, 2015
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
April 10, 2018
Record last verified: 2018-04